Instacart Q3 Results Show Growth, Cautious Q4

Instacart Q3 results showed solid growth and an expanded buyback while management issued cautious Q4 guidance that may tighten trader positioning.

November 10, 2025·2 min read
View all news articles
Minimalist vector control knob on solid cobalt-blue background evoking Instacart Q3 results, buyback and cautious Q4 guidance.

KEY TAKEAWAYS

  • Q3 revenue was $939M with GTV $9.17B and 83.4M orders, producing $278M adjusted EBITDA.
  • Management expanded the share-repurchase program by $1.5B and began a $250M accelerated buyback.
  • Management flagged EBT/SNAP funding uncertainty and competition as reasons for cautious Q4 guidance.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Instacart’s third-quarter results on Nov. 10, 2025, showed continued growth and led management to expand its share-repurchase program by $1.5 billion while launching a $250 million accelerated buyback. Despite strong demand, executives issued cautious guidance for the fourth quarter, citing broad macroeconomic pressures.

Quarterly Performance and Strategic Drivers

Instacart reported third-quarter revenue of $939 million, up 10.2% year-over-year, with gross transaction value (GTV) reaching $9.17 billion. Adjusted EBITDA, a proxy for operating profit, was $278 million, and orders rose 14% to 83.4 million. Transaction revenue totaled $670 million, and advertising and other revenue reached $269 million, each increasing 10% year-over-year.

The company attributed growth in orders and GTV to rising user numbers and higher order frequency. However, average order value declined 4% due to a larger share of restaurant orders and a $10 basket minimum for Instacart+ members, which weighed on per-order spending.

Strategic partnerships with Kroger, Albertsons, and Target supported omnichannel integration and customer retention. Instacart also credited AI-powered personalization and improved price transparency with reducing cart abandonment. Its health-focused offerings under Instacart Health continued to diversify revenue streams.

Guidance and Capital Allocation

For the fourth quarter, Instacart projected GTV between $9.45 billion and $9.6 billion, implying 9.0–11.0% year-over-year growth. Advertising revenue was forecast to rise 6.0–9.0%, and adjusted EBITDA was expected between $285 million and $295 million.

Management noted strong demand through October and ongoing enterprise momentum but flagged macroeconomic risks, including uncertainties around EBT/SNAP funding and intensifying competition. This cautious outlook placed guidance slightly below consensus estimates.

Alongside the results, Instacart expanded its share-repurchase program by $1.5 billion and initiated a $250 million accelerated buyback, signaling confidence in its operational momentum despite the guarded outlook.

No material regulatory actions, approvals, or mergers and acquisitions were disclosed for the quarter.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

U.S.-Switzerland Trade Deal Lowers Tariffs

U.S.-Switzerland trade deal eases pressure on Swiss watch and pharmaceutical exporters and reduces a near-term sales and pricing headwind for traders.

Ron Baron Tesla Sees $2,500 Target, Holds Stakes

Ron Baron Tesla reaffirmed a lifetime hold and backed Musk's pay package, spotlighting governance and focusing investors on his $2,500 Tesla price target.

StubHub Q3 Earnings: Stock Falls After Guidance Withheld

StubHub Q3 earnings showed revenue growth but a large IPO-related net loss and no Q4 guidance, prompting a steep share selloff and pressured positioning.

Lundbeck Bid for Avadel Tops Alkermes Deal

Lundbeck Bid for Avadel raises takeover stakes by topping Alkermes' signed agreement and could force matching or renegotiation that reshapes deal certainty

Merck To Acquire Cidara Therapeutics

Merck to acquire Cidara strengthens its antiviral and respiratory pipeline ahead of Keytruda patent expiry and shifts near-term trader positioning.

Walmart CEO Transition Names John Furner

Walmart CEO transition names John Furner; the board appointment and handover aim to preserve operational continuity and limit governance uncertainty.